文章引用说明 更多>> (返回到该文章)

Q. Cheng, P. S. Leung. An update on the islet renin-angiotensin system. Peptides, 2011, 32(5): 1087-1095.

被以下文章引用:

  • 标题: 肾素–血管紧张素–醛固酮系统对胰岛素分泌的调节作用The Regulatory Effect of Renin-Angiotensin-Aldosterone System on Insulin Secretion

    作者: 贾英丽, 杨宝学

    关键字: 胰岛素分泌, 血管紧张素, 血管紧张素转化酶, 醛固酮 Insulin Secretion; Angiotensin; Angiotensin Converting Enzyme; Aldosterone

    期刊名称: 《Journal of Physiology Studies》, Vol.1 No.3, 2013-11-08

    摘要: 糖尿病严重威胁着人类的健康,而糖尿病的发生与胰岛功能失调有密切联系。肾素–血管紧张素–醛固酮系统在胰岛表达,并对胰岛功能和胰岛素分泌具有调节作用。其中,血管紧张素II和醛固酮能够抑制胰岛素分泌,而血管紧张素转化酶2活性升高可促进胰岛素分泌。同时,血管紧张素转化酶抑制剂能够预防胰腺的炎症反应及纤维化,抑制胰岛内部的细胞凋亡,进而改善胰岛功能、促进胰岛素分泌。而血管紧张素受体拮抗剂能增加胰腺血流量及预防炎症反应及纤维化,从而促进胰岛素分泌。因此,肾素–血管紧张素–醛固酮系统可能成为糖尿病的治疗靶点。 Diabetes mellitus is a serious threat to human health and its occurrence is closely related to islet dysfunction. The renin-angiotensin-aldosterone system is expressed in islets and plays an important role in islet function and insulin secretion. Angiotensin II and aldosterone can inhibit the secretion of insulin. Angiotensin-converting enzyme promotes insulin secretion. The angiotensin converting enzyme inhibitor can improve pancreatic function and insulin secretion via the amelioration of intra-islets inflammation, fibrosis and apoptosis. The angiotensin receptor blocker can ameliorate intra-islets inflammation, fibrosis so as to improve insulin secretion. Renin-angiotensin-aldosterone system may become a therapeutic target for the treatment of diabetes.

在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享